WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...
AstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic name dapagliflozin, was ...
(RTTNews) - The US Food and Drug Administration AstraZeneca's Farxiga (dapagliflozin) to improve glycemic control in pediatric patients with type-2 diabetes or T2D aged 10 years and older. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback